Targeting the metastasis suppressor NDRG1 for the treatment of pancreatic cancer. [ 2012 - 2017 ]

Research Grant

Researchers: Dr Zaklina Kovacevic (Principal investigator)

Brief description We will investigate NDRG1, a novel molecular target that has been demonstrated to inhibit the progression of numerous cancers. We aim to better understand the underlying functions of NDRG1 in pancreatic cancer and how we can potentially target this gene with novel therapeutics being developed in our laboratory. We hope that this new approach will lead to more promising treatment options and a better outcome for those suffering from pancreatic cancer.

Funding Amount $AUD 327,142.18

Funding Scheme Early Career Fellowships

Notes Peter Doherty Biomedical ECF